Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,444.25
(
0.58%
)
US TECH 100
28,635.60
(
0.17%
)
Dow Jones
49,693.20
(
-0.14%
)
Brent Oil
104.18
(
0.47%
)
Bitcoin
79,646.77
(
0.46%
)
News Focus
News Focus
Post# of 257556
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122977
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rkrw post# 86193

Thursday, 11/12/2009 2:29:38 PM

Thursday, November 12, 2009 2:29:38 PM

Post# of 257556
TLCR:

They could be at a big risk when/if (in pivotal studies) the bax/halo one monthly injection formulation comes out. Talecris is working on their own injectable but it's once weekly, 4 injections and needs 40% more drug because of bioavailability issues. Given the cogs it seems like a non-starter to me.

TCLR’s insiders presumably agree—they unloaded $400M of stock concurrently with the IPO.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today